Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas-Reference-Cited by-同舟云学术

Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas

Published:2017-07-11 Issue:52 Volume:8 Page:89607-89619
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yin Anan¹,Etcheverry Amandine²³⁴,He Yalong¹,Aubry Marc³⁵,Barnholtz-Sloan Jill⁶,Zhang Luhua¹⁷,Mao Xinggang¹,Chen Weijun¹,Liu Bolin⁸,Zhang Wei¹,Mosser Jean²³⁴⁵,Zhang Xiang¹

Affiliation:

1. Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi Province, The People's Republic of China

2. CNRS, UMR 6290, Institut de Génétique et Développement de Rennes (IGdR), Rennes, France

3. Université Rennes1, UEB, UMS 3480 Biosit, Faculté de Médecine, Rennes, France

4. CHU Rennes, Service de Génétique Moléculaire et Génomique, Rennes, France

5. Plate-forme Génomique Santé Biosit, Université Rennes1, Rennes, France

6. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, United States of America

7. Department of Neurosurgery, No. 425 Hospital of the People's Liberation Army, San Ya, Hainan Province, The People's Republic of China

8. Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, United States of America

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole gain of chromosome 19, not co-gain of chromosomes 19 and 20, characterizes a class of glioblastomas with more favorable outcomes;Journal of Neuropathology & Experimental Neurology;2023-11-14

2. Genome‐wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non‐G‐CIMP glioblastomas with unmethylated MGMT promoter: MGMT‐dependent roles of GPR81;CNS Neuroscience & Therapeutics;2023-10-13

3. Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter;Epigenomics;2022-10

4. Obesity-Associated Differentially Methylated Regions in Colon Cancer;Journal of Personalized Medicine;2022-04-20

5. Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide;Cochrane Database of Systematic Reviews;2021-03-12